About Jaguar Health Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://jaguar.health/
Frequently Asked Questions
What is the 52-week range for JAGX?
The 52-week high is $1267.95 and the 52-week low is $2.35.
What is the P/E ratio for JAGX?
The P/E ratio data is currently unavailable.
What is the dividend yield for JAGX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -362.42%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -130.85%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.22.
Analyst Recommendation Trends
Wall Street analyst consensus for JAGX over the last few months:
Latest JAGX News
Jaguar Health Announces a Special Stock Dividend
Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluation of strategic alternativesSAN FRANCISCO, CA / ACCESS Newswire / October 2, 2026 / (NASDAQ:JAGX) ("Jaguar" or "the Company") today announced that its Board of Directors has declared a special stock dividend (the "Special Stock Dividend") to holders of Jaguar Common Stock and certain outstanding warrants as of record on October 13, 2026. The Special Stock Dividend will consist of the Company's Se
Napo Pharmaceuticals Crofelemer Study Accepted for Presentation at ACG 2026
Napo Pharmaceuticals, a subsidiary of Jaguar Health (NASDAQ:JAGX), said an abstract covering preliminary results from an ongoing study of crofelemer in adults with short bowel syndrome with intestinal failure has been accepted for presentation at the American College of Gastroenterology Annual Scientific Meeting. ACG 2026 is scheduled to take place from October 9 to October 14 in Nashville, Tennessee.
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting
ACG 2026 takes place October 9-14, 2026 in Nashville, Tennessee.Napo is conducting a multicenter, randomized double-blind placebo-controlled Phase 2 clinical trial in adult Type 1 short bowel syndrome (SBS) patients without colin-in-continuity.
Jaguar Health Soars 32% as Rare-Disease Pipeline News Meets Thin Post-Split Float
Jaguar Health is surging on a float so thin that a handful of trades can swing the price wildly, while a rare pediatric disease program edges closer to a pivotal regulatory filing that could either validate the rally or expose how fragile it really is.
Gapping stocks in Friday's session
The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.
Jaguar Health Stock Surges Friday: What's Happening?
Jaguar Health is surging Friday after announcing debt-for-equity exchanges that cut debt by over $6.7 million and retired a promissory note.
Jaguar Health Announces Issuance Of 182,091 Shares To Streeterville Capital For $1.67832M Reduction In 2021 Note Balance; 2025 Streeterville Note Fully Paid And Cancelled Following Exchange For 547,898 Shares
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001585608/000119312526401239/d130901d8k.htm
Unusual volume stocks in Thursday's session
Unusual volume stocks in Thursday's session
Jaguar Health Stock Slides Thursday: What's Happening?
Jaguar Health shares are sliding Thursday as equity dilution concerns weigh on the company following a debt-for-equity exchange.
The market is filled with gapping stocks in Thursday's session.
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Viking Therapeutics Sinks 15% After Pricing Upsized $500M Offering; Jaguar Health Tumbles 25%
Two biotech stocks are getting crushed while the sector benchmark climbs, and the reasons behind each selloff could not be more different. Understanding what separates a deliberate corporate move from pure micro-cap chaos is the key to reading both situations correctly.
Reported Earlier: Jaguar Health Issues 547,898 Common Shares To Streeterville Capital To Retire ~$5.05M Of Outstanding Promissory Note
As previously disclosed, on November 12, 2025, Jaguar Health, Inc. (the "Company") issued and sold to Streeterville Capital, LLC ("Streeterville") a secured promissory note in the original principal
Jaguar Health Files Supplement To Offer Up To ~$9.82M Of Common Stock Under At-The-Market Offering Program
JAGUAR HEALTH, INC.Up to $9,824,188Shares of Common Stock This supplement No. 8 (this "Supplement) amends and supplements certain information contained in the prospectus supplement, dated May 23, 2024, as amended by
Let's take a look at the stocks that are in motion in today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after-market session. The market value of their outstanding shares is at $1.7 million. Greenland Mines (NASDAQ:GRML) shares
Wednesday's session: top gainers and losers
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Two Biotechs Get Beaten Down: Jaguar Health Collapses 59%, Viking Therapeutics Sinks 4%
Jaguar Health and Viking Therapeutics are both sinking Wednesday morning, but the forces behind each drop point in completely different directions, and the broader biotech sector is barely flinching.
Gapping stocks in Wednesday's session
Let's have a look at the gap up and gap down stocks in today's session.
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Artelo Biosciences (NASDAQ:ARTL) shares rose 216.1% to $13.12 during Wednesday's regular session. The market value of their outstanding shares is at $2.2 million. Vistagen Therapeutics (NASDAQ:VTGN) shares
Stay updated with the stocks that are on the move in today's pre-market session.
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Jaguar Health Stock Plunges Wednesday: What's Happening?
Jaguar Health shares are plunging Wednesday morning as profit-taking reverses an explosive Tuesday rally sparked by regulatory fee waivers.
Dow Falls 100 Points; General Mills Posts Upbeat Q1 Earnings
U.S. stocks fell Wednesday; General Mills beat estimates, energy rose, utilities declined, while oil gained and gold dropped.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers IM Cannabis (NASDAQ:IMCC) stock rose 56.3% to $6.47 during Wednesday's pre-market session. The company's market cap stands at $2.5 million. Vistagen Therapeutics (NASDAQ:VTGN) shares increased by
JAGX Stock Soars Over 10% Premarket After Best Day In Over 8 Years: What’s Driving The Surge?
Jaguar Health aims to file for approval of its Crofelemer powder treatment for pediatric MVID in mid-2027.
InnovAge, Voyager Technologies And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. futures edged higher; InnovAge fell 9.4% after a 10M-share offering. Jaguar Health, Voyager Technologies and other stocks also dropped premarket.
Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Worthington Enterprises surged 15.9% premarket after beating Q1 EPS and sales estimates; Wheeler REIT led gainers, while Jaguar Health and Biomea fell.
Jaguar Health Stock Surged 1200% on Tuesday: Here's Why JAGX Stock Is Trending After Hours
Jaguar Health shares jumped 5.19% after hours following FDA fee waivers for two of its commercialized therapies.
Jaguar Health, IONQ, Viking Therapeutics, Xanadu Quantum and Grab Holdings: Why These 5 Stocks Are on Investors' Radars Today
JAGX, IONQ, VKTX, XNDU, GRAB were among the stocks seen trending on Tuesday, Sept. 22, 2026.
These stocks are moving in today's after hours session
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 32.2% to $45.56 during Tuesday's after-market session. The company's market cap stands at $1.1 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares
What's going on in today's session
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Jaguar Health (NASDAQ:JAGX) stock increased by 304.5% to $10.8 during Tuesday's regular session. The company's market cap stands at $1.1 million. Greenland Mines (NASDAQ:GRML) shares moved upwards by
Jaguar Health Receives Fee Waivers from FDA
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and SBS for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027SAN FRANCISCO, CA / ACCESS Newswire / September 22, 2026 / (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that the U. Food and Drug Administration (FDA) has granted Napo's request for a waiver of the fee associated with the Pres
FDA Grants Jaguar Health Family Company Napo Pharma's Request For Waiver Of Fee Associated With PDUFA For Mytesi For 2027 Fiscal Year
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and SBS for crofelemer powder for oral solution, targeting an NDA filing
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Keep an eye on the top gainers and losers in Tuesday's session.
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Jaguar Health, Inc. Announces Reverse Stock Split
The Company's Common Stock will begin trading on a split-adjusted basis when the market opens on the Effective Date and will remain listed on The Nasdaq Capital Market under the symbol "JAGX". The new CUSIP number for the Company's Common Stock following the reverse stock split is 47010C854.
Jaguar Health To Effect 1-For-15 Reverse Stock Split Of Common Stock On September 17
Reverse split approved at April 2026 Special Meeting of StockholdersShares of Jaguar Health common stock to begin trading on split-adjusted basis on September 17, 2026Reverse split approved at April 2026 Special Meeting
All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
The trial is ongoing at multiple centers in the United States, the European Union, and the United Arab Emirates. This trial is expected to support a New Drug Application (NDA) filing for the treatment of the MVID indication in mid-2027.
Jaguar Health Announces All Pediatric Participants In Napo Pharmaceuticals' Crosover Clinical Study Have Entered Extension Phase To Get Doses Of Crofelemer To Treat Microvillus Inclusion Disease
Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that all randomized pediatric MVID patients in Napo's pivotal crossover clinical trial have entered the
Top movers analysis one hour before the close of the markets on 2026-09-08: top gainers and losers in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Top movers analysis in the middle of the day on 2026-09-08: top gainers and losers in today's session.
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
Jaguar Health Launches Neonorm Dog on Amazon, Expanding Animal-Health Product Franchise
The non-prescription digestive-support product extends Jaguar Health’s Neonorm franchise into the companion-animal market, with additional online and retail distribution expected shortly. Key Investor TakeawaysJaguar Health (NASDAQ:JAGX) has launched Neonorm Dog on Amazon as part of the commercial rollout of its new non-prescription animal-health product.
There are notable gap-ups and gap-downs in today's session.
The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogsJaguar expects Neonorm Dog to be available through other select online and animal health retail channels shortly, including ChewySAN FRANCISCO, CA / ACCESS Newswire / September 8, 2026 / (NASDAQ:JAGX) ("Jaguar") today announced that Neonorm Dog is now available on Amazon. A new
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million. Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by
Curious about the stocks that are showing activity after the closing bell on Monday?
Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics.
Stay updated with the stocks that are on the move in today's after-hours session.
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 10.4% to $1.7 during Friday's after-market session. The market value of their outstanding shares is at $3.8 million. Genelux (NASDAQ:GNLX) stock moved upwards by
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Immuron (NASDAQ:IMRN) shares moved upwards by 48.2% to $1.65 during Friday's regular session. The market value of their outstanding shares is at $8.9 million. bioAffinity Technologies (NASDAQ:BIAF) shares
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Napo remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS) for pediatric rare IF diseases, including microvillus inclusion disease (MVID) and short bowel syndrome with IF (SBS-IF). In June 2026, as announced, data was presented at the 58th Annual European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN) Meeting in Lille, France from ongoing investigational studies with oral liquid crofelemer
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2025-12-11 | MICEK JOHN | +7,377 | - | - |
| 2025-12-11 | MICEK JOHN | +7,377 | - | - |
| 2025-12-11 | King Steven R. | +11,740 | - | - |
| 2025-12-11 | King Steven R. | +11,740 | - | - |
| 2025-12-11 | Wolin Jonathan S. | +11,740 | - | - |
| 2025-12-11 | Wolin Jonathan S. | +11,740 | - | - |
| 2025-12-11 | CONTE LISA A | +28,592 | - | - |
| 2025-12-11 | CONTE LISA A | +28,592 | - | - |
| 2025-12-11 | Chaturvedi Pravin R | +11,740 | - | - |
| 2025-12-11 | Chaturvedi Pravin R | +11,740 | - | - |
| 2025-12-11 | Siegel Jonathan B. | +7,377 | - | - |
| 2025-12-11 | Siegel Jonathan B. | +7,377 | - | - |
| 2025-12-11 | Jayasuriya Anula | +5,870 | - | - |
| 2025-12-11 | Jayasuriya Anula | +5,870 | - | - |
| 2025-12-11 | Lizak Carol R. | +11,740 | - | - |
| 2025-12-11 | Lizak Carol R. | +11,740 | - | - |
| 2025-12-11 | BOCHNOWSKI JAMES J | +6,363 | - | - |
| 2025-12-11 | BOCHNOWSKI JAMES J | +6,363 | - | - |